Marimastat in Patients With Advanced Pancreatic Cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 • 5,683 citations

Matrix Metalloproteinases: A Review

1993 • 2,998 citations

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1991 • 2,774 citations

Changing views of the role of matrix metalloproteinases in metastasis

1997 • 1,585 citations

Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis

1993 • 606 citations

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

1995 • 511 citations

Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library

1995 • 474 citations

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1994 • 444 citations

Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and Marimastat

1997 • 403 citations

Type IV collagenases in invasive tumors

1993 • 256 citations

Matrix metalloproteinase inhibition: A review of anti-tumour activity

1995 • 226 citations

Human Macrophage Metalloelastase. GENOMIC ORGANIZATION, CHROMOSOMAL LOCATION, GENE LINKAGE, AND TISSUE-SPECIFIC EXPRESSION

1995 • 156 citations

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1998 • 104 citations

Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer

1987 • 65 citations

Prognostic Values of Preoperative and Postoperative CEA and CA19.9 Levels in Pancreatic Cancer

1994 • 56 citations